The Expander-2 trial randomly assigned men with BPH symptoms at 23 sites in the US and Canada to receive a temporary nitinol urethral implant, Urocross Expander, or a sham procedure.

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

August 10, 2023 – Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH) ...

Dear Dr. Roach: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn't provide any ...

Credit: Getty Images This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men. Familial clustering studies ...

Men with benign prostatic hyperplasia (BPH) appear to have higher risks for chronic kidney disease (CKD) and kidney stones. Men with benign prostatic hyperplasia (BPH) are at increased risk for ...

The US Food and Drug Administration has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia (BPH). Designed and marketed ...

Obstructive uropathy is a blockage that prevents urine from flowing naturally through the urinary system. The blockage may cause significant pain, nausea, and difficulty urinating. Several factors can ...

During the procedure, surgeons observed significant enlargement of the prostate and bladder changes associated with long-term ...